← Eichor
Study identifier: NCT03329313 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Effects of Variation of Sodium Dialysate in ICU

Condition: Acute Kidney Injury · Renal Replacement Therapy  ·  Sponsor: University Hospital, Montpellier

PhasePhase 2
Planned participants158
Who can joinAll sexes, 18 Years to 80 Years
Healthy volunteersNo

About this study

Intermittent hemodialysis/diafiltration is a current renal replacement therapy (RRT) institued for ICU patients with AKI. For a better clinical tolerance, iinternational guidelines advise to use cold dialysate, increase duration session, decrease blood and dialysate flows, and increase level of sodium dialysate concentration (≥ 145mmol/l). Indeed, the use of a Na concentration dialysate \> 145 mmol/l improves intradialytic hemodynamic tolerance but it may also induce fluid overload by the transfert of sodium from the dialysate compartment to the blood. Yet, fluid overload has been strongly associated with mortality in critically ills. The investigators hypothesized that the use of a level in sodium dialysate at 140 mmol/l with slow low efficiency daily dialysis-filtration (SLEDD-f) will permit a fair intradialytic hemodynamic tolerance without the adverse effect of intradiaclytic Na loading from the dialysate. Two randomized groups of ICU AKI patients treated by SLEDD-f will be compared in terms of intradialytic hemodynamic tolerance and overload accordong to 140 or 145 mmol/l of Na in the dialysate

This description comes directly from the study's public registry record.

Talk to the study team

vincent BRUNOT, MD  ·  467332495  ·  v-brunot@chu-montpellier.fr

kada KLOUCHE, MD, PhD  ·  467338441  ·  k-klouche@chu-montpellier.fr

Always discuss trial participation with your own doctor first.

Locations (1)

UhmontpellierMontpellier, Montpellier, FranceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT03329313